Need advice in managing cancer immunotherapy cardiotoxicity?

Request Assistance

FDA Public Workshop: Assessment of Cardiovascular Toxicities in Immuno-oncology Trials
Posted by Moslehi on January 22, 2018

On Friday, December 1, 2017, the U.S. Food & Drug Administration (FDA) announced a public workshop entitled, “Assessment of Cardiovascular Toxicities in Immuno-oncology Trials”. This workshop provided a forum for discussion of cardiovascular toxicities in immuno-oncology clinical trials. The workshop focused on the identification...

Read More
Manuscripts published in Circulation raise awareness for immune checkpoint inhibitor associated myocarditis
Posted by Moslehi on January 22, 2018

Two manuscripts published on November 21, 2017 of the journal Circulation bring additional awareness for the syndrome of immune checkpoint-inhibitor (ICI)-associated myocarditis. Thuny and colleagues (Hospital Nord, Marseille, France) present a case series of 30 patients with ICI-induced cardiotoxicity. Cardiotoxicity was diagnosed at a...

Read More
Cardio-Oncology highlighted at American Heart Association Annual Meeting 2017
Posted by Moslehi on January 22, 2018

There were several cardio-oncology sessions at the American Heart Association (AHA) annual meeting which occurred in November 2017 in Anaheim, California. A session called “The Emerging Science of Cardio-Oncology” focused on the rapidly evolving area of clinical practice in cancer patients with heart failure or acute coronary...

Read More
View All
connect with us

Fully agree with our colleagues at @VUmedicine in this JAMA editorial: we need new research and informed guidelines on CV care for patients with cancer. Our Centre has a major focus in this area. @CardioOncology

Congrats 2 @LorenzLehmann for setting up a terrific #CardioOnc program at @HeidelbergU really enjoyed the conference today! @DrJESalem @Kardioonkologie @ChristophMaack @unico_greco @franckthuny @escardio @DLenihanICOS_MD @arjunkg @PrevCardioOnc @oncology_cardio @OSUCardioOnc

Trans-Atlantic conference continues! Role of MRI in ICI-myocarditis? Intriguing data from our colleagues at Heidelberg! @VUMC_heart @LorenzLehmann @Kardioonkologie @ChristophMaack @unico_greco @onco_cardiology @venkmurthy @cshenoy3 @AChoiHeart @JoaoLCavalcante @GE_MRI @escardio

Trans-Atlantic #CardioOnc conference with great presentation by @LorenzLehmann from A+ cardio-oncology program at @Kardioonkologie Lots of challenges in ICI-myocarditis! @unico_greco @DrJESalem @onco_cardiology @DLenihanICOS_MD @datsunian @franckthuny @arjunkg @myocarditisfndn